AnalystsCarey MacruryCarey Macrury's Stock Forecasts
AnalystsCarey Macrury
Sectors:
Analyst Ranking
Top 31%
#1607 out of 5177 analysts
Average Return
+23.86%
Win Rate
64%7 out of 11
Risk vs Reward
Poor
Good
Carey Macrury's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Gold Royalty CorpGROY | +129.17% | $2.16 | $4.95 | 2025-06-10 - 2026-01-16 | Strong Buy |
Aris Mining CorpARMN | +103.14% | $8.91 | $18.10 | 2025-09-03 - 2026-01-16 | Strong Buy |
Iamgold CorpIAG | +99.51% | $6.11 | $12.19 | 2024-10-21 - 2025-10-21 | Strong Buy |
Gatos Silver IncGATO | +42.29% | $10.12 | $14.40 | 2024-04-22 - 2025-01-15 | Strong Buy |
Newmont CorpNEM | +15.04% | $45.61 | $52.47 | 2022-07-26 - 2023-01-19 | Strong Buy |
Carey Macrury Analyst Color
Get additional color on Carey Macrury's coverage of popular stocks
Carey Macrury's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Aris Mining CorpARMN | 1 | Strong Buy | $17.00 | -6.08% | Maintains | 4 months ago |
Gold Royalty CorpGROY | 1 | Strong Buy | $3.00 | -39.39% | Initiates Coverage On | 7 months ago |
Eldorado Gold CorpEGO | 1 | Hold | $27.00 | -32.97% | Maintains | 8 months ago |
Iamgold CorpIAG | 2 | Strong Buy | $10.50 | N/A | Upgrades | a year ago |
Gatos Silver IncGATO | 1 | Strong Buy | $12.50 | N/A | Upgrades | 2 years ago |
Aptose Biosciences IncAPTOF | 1 | Strong Buy | $3,600.00 | N/A | Maintains | 3 years ago |
Newmont CorpNEM | 5 | Strong Buy | $55.00 | N/A | Upgrades | 3 years ago |
Royal Gold IncRGLD | 2 | Strong Buy | $140.00 | N/A | Upgrades | 4 years ago |
Maverix Metals IncMMX | 1 | Strong Buy | $8.25 | N/A | Upgrades | 5 years ago |
Centerra Gold IncCGAU | 1 | Buy | $14.50 | N/A | Downgrades | 5 years ago |
Agnico Eagle Mines LtdAEM | 1 | Strong Buy | $110.00 | N/A | Maintains | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.